Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-005645

Chief Financial Officer acquired 2,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

PISKEL KYLE · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-14 Exercise or conversion : show line 1 in the form +2,500 $6.32 $15,800 271,510 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-14 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −2,500 0 D
Loading xslF345X05/form4.xml…